Clinical Trial Update: Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing ALTH12 to mesalamine enema in left-sided ulcerative colitis has completed, assessing safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ALTH12
• Mesalamine Enema (mesalamine enema)

Snippet

Sponsor: Altheus Therapeutics, Inc. | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED